Statement
22 Jun 2026
2026 UN High-Level Meeting on HIV/AIDS
On 22 June 2026, IFPMA delivered a statement at the UN High-Level Meeting on HIV/AIDS in New York. Excellencies, distinguished delegates, I am pleased to speak on behalf of the IFPMA, representing the innovative pharmaceutical industry. As Member States gather at this High-Level Meeting to renew global commitments on HIV/AIDS, IFPMA welcomes the Political Declaration’s...
Read more
Statement
18 Jun 2026
Pharmaceutical innovation key to delivering G7 leaders’ growth agenda
The global innovative pharmaceutical industry welcomes the G7 leaders’ commitment to strengthening international cooperation and advancing a balanced and durable growth agenda. IFPMA reiterates that a strong life sciences sector is critical to support these shared objectives.
Read more
Press release
17 Jun 2026
Pharmaceutical industry mobilizes to support response to the Ebola Bundibugyo virus disease outbreak and calls for a system that enables rapid response and sustained R&D investment
The global pharmaceutical industry underlines the commitment of the sector to support the response to the latest Ebolavirus outbreak, and calls for the latest outbreak to be a “wake up call” for negotiators discussing the details of the Pandemic Agreement.
Read more
